Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

Histogenics logo

About Histogenics Stock (NASDAQ:HSGX)

Key Stats

Today's Range
$0.91
$0.98
50-Day Range
$0.16
$3.07
52-Week Range
$0.08
$1.43
Volume
2.82 million shs
Average Volume
9.06 million shs
Market Capitalization
$90.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.

Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

HSGX Stock News Headlines

Traphaco JSC TRA
Rigged election?
Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.
See More Headlines

HSGX Stock Analysis - Frequently Asked Questions

Histogenics Corp (NASDAQ:HSGX) issued its quarterly earnings data on Thursday, August, 9th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.10.

Histogenics (HSGX) raised $60 million in an initial public offering (IPO) on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogenics investors own include Interpace Biosciences (IDXG), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), Novavax (NVAX), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and OPKO Health (OPK).

Company Calendar

Last Earnings
8/09/2018
Today
11/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
$-8,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
$90.58 million
Optionable
Not Optionable
Beta
3.10
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:HSGX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners